DOCSLIB.ORG

2019 Q2 Vote Report.Xlsx

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2019 Q2 Vote Report.Xlsx Loyola University of Chicago Proxy Vote History ISS Meeting Meeting Shares Agenda Standard Catholic LUC Vote Record Date Date Company Ticker Country Type Voted Item No. Agenda Item Proponent Mgmt Rec Rec Policy Rec Cast 2/4/2019 4/3/2019 Hewlett Packard Enterprise Company HPE USA Annual 27,781 1a Elect Director Daniel Ammann Management For For For For 2/4/2019 4/3/2019 Hewlett Packard Enterprise Company HPE USA Annual 27,781 1b Elect Director Michael J. Angelakis Management For For For For 2/4/2019 4/3/2019 Hewlett Packard Enterprise Company HPE USA Annual 27,781 1c Elect Director Pamela L. Carter Management For For For For 2/4/2019 4/3/2019 Hewlett Packard Enterprise Company HPE USA Annual 27,781 1d Elect Director Jean M. Hobby Management For For For For 2/4/2019 4/3/2019 Hewlett Packard Enterprise Company HPE USA Annual 27,781 1e Elect Director Raymond J. Lane Management For For For For 2/4/2019 4/3/2019 Hewlett Packard Enterprise Company HPE USA Annual 27,781 1f Elect Director Ann M. Livermore Management For For For For 2/4/2019 4/3/2019 Hewlett Packard Enterprise Company HPE USA Annual 27,781 1g Elect Director Antonio F. Neri Management For For For For 2/4/2019 4/3/2019 Hewlett Packard Enterprise Company HPE USA Annual 27,781 1h Elect Director Raymond E. Ozzie Management For For For For 2/4/2019 4/3/2019 Hewlett Packard Enterprise Company HPE USA Annual 27,781 1i Elect Director Gary M. Reiner Management For For For For 2/4/2019 4/3/2019 Hewlett Packard Enterprise Company HPE USA Annual 27,781 1j Elect Director Patricia F. Russo Management For For For For 2/4/2019 4/3/2019 Hewlett Packard Enterprise Company HPE USA Annual 27,781 1k Elect Director Lip-Bu Tan Management For For For For 2/4/2019 4/3/2019 Hewlett Packard Enterprise Company HPE USA Annual 27,781 1l Elect Director Mary Agnes Wilderotter Management For For For For 2/4/2019 4/3/2019 Hewlett Packard Enterprise Company HPE USA Annual 27,781 2 Ratify Ernst & Young LLP as Auditors Management For For For For 2/4/2019 4/3/2019 Hewlett Packard Enterprise Company HPE USA Annual 27,781 3 Advisory Vote to Ratify Named Executive Officers' Compensation Management For For For For 2/4/2019 4/3/2019 Hewlett Packard Enterprise Company HPE USA Annual 27,781 4 Provide Right to Act by Written Consent Share Holder Against For For For 3/11/2019 4/11/2019 First Data Corp. FDC USA Written Consent 7,768 1 Approve Merger Agreement Management For Abstain Abstain Abstain 3/11/2019 4/11/2019 First Data Corp. FDC USA Written Consent 7,768 2 Advisory Vote on Golden Parachutes Management For Abstain Abstain Abstain 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 1 Open Meeting 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 2.a Receive Director's Report (Non-Voting) 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 2.b Implementation of Remuneration Policy 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 2.c Receive Explanation on Company's Reserves and Dividend Policy Management <Unknown> <Unknown> <Unknown> Refer 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 2.d Adopt Financial Statements and Statutory Reports Management For For For For 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 2.e Approve Dividends of EUR 0.65 Per Share Management For For For For 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 2.f Approve Discharge of Directors Management For For For For 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 3.a Reelect John Elkann as Executive Director Management For Against Against Against 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 3.b Reelect Michael Manley as Executive Director Management For For For For 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 3.c Elect Richard Palmer as Executive Director Management For For For For 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 4.a Reelect Ronald L. Thompson as Non-Executive Director Management For For For For 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 4.b Reelect John Abbott as Non-Executive Director Management For For For For 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 4.c Reelect Andrea Agnelli as Non-Executive Director Management For For For For 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 4.d Reelect Tiberto Brandolini d'Adda as Non-Executive Director Management For For For For 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 4.e Reelect Glenn Earle as Non-Executive Director Management For For For For 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 4.f Reelect Valerie A. Mars as Non-Executive Director Management For For For For 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 4.g Reelect Michelangelo A. Volpi Non-Executive as Director Management For For For For 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 4.h Reelect Patience Wheatcroft Non-Executive as Director Management For For For For 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 4.i Reelect Ermenegildo Zegna Non-Executive as Director Management For For For For 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 5 Ratify Ernst & Young as Auditors Management For For For For 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 6.1 Grant Board Authority to Issue Shares Up To 10 Percent of Issued Capital in Case of Acquisition Management For For For For 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 6.2 Authorize Board to Exclude Preemptive Rights from Share Issuances Under Item 6.1 Management For For For For 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 6.3 Grant Board Authority to Issue Special Voting Shares and Right to Subscription Up to Maximum Aggregate Sp Management For Against Against Against 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 7 Authorize Repurchase of Up to 10 Percent of Issued Share Capital Management For For For For 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 8 Approve Cancellation of Special Voting Shares Management For For For For 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 9.a Approve CEO Bonus Management For Against Against Against 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 9.b Approve Award of Performance Shares to Executive Directors Management For Against Against Against 3/15/2019 4/12/2019 Fiat Chrysler Automobiles NV FCA Netherlands Annual 6,566 10 Close Meeting 2/19/2019 4/16/2019 Citigroup Inc. C USA Annual 14,684 1a Elect Director Michael L. Corbat Management For For For For 2/19/2019 4/16/2019 Citigroup Inc. C USA Annual 14,684 1b Elect Director Ellen M. Costello Management For For For For 2/19/2019 4/16/2019 Citigroup Inc. C USA Annual 14,684 1c Elect Director Barbara J. Desoer Management For For For For 2/19/2019 4/16/2019 Citigroup Inc. C USA Annual 14,684 1d Elect Director John C. Dugan Management For For For For 2/19/2019 4/16/2019 Citigroup Inc. C USA Annual 14,684 1e Elect Director Duncan P. Hennes Management For For For For 2/19/2019 4/16/2019 Citigroup Inc. C USA Annual 14,684 1f Elect Director Peter B. Henry Management For For For For 2/19/2019 4/16/2019 Citigroup Inc. C USA Annual 14,684 1g Elect Director S. Leslie Ireland Management For For For For 2/19/2019 4/16/2019 Citigroup Inc. C USA Annual 14,684 1h Elect Director Lew W. (Jay) Jacobs, IV Management For For For For 2/19/2019 4/16/2019 Citigroup Inc. C USA Annual 14,684 1i Elect Director Renee J. James Management For For For For 2/19/2019 4/16/2019 Citigroup Inc. C USA Annual 14,684 1j Elect Director Eugene M. McQuade Management For For For For 2/19/2019 4/16/2019 Citigroup Inc. C USA Annual 14,684 1k Elect Director Gary M. Reiner Management For For For For 2/19/2019 4/16/2019 Citigroup Inc. C USA Annual 14,684 1l Elect Director Diana L. Taylor Management For For For For 2/19/2019 4/16/2019 Citigroup Inc. C USA Annual 14,684 1m Elect Director James S. Turley Management For For For For 2/19/2019 4/16/2019 Citigroup Inc.
Load more

Recommended publications
  • Area Companies Offering Matching Gifts Below Is a Partial List of Area Companies Offering Matching Gifts
    Area Companies Offering Matching Gifts Below is a partial list of area companies offering matching gifts. Please check to see if your employer is on the list and/or check with your company if they offer the program. If your employer offers a matching gift program, please request a matching gift form from your employer or fill out their online form. Matching gifts can be made to the Tredyffrin Township Libraries, Paoli Library or Tredyffrin Public Library. Aetna FMC Corporation PNC Financial Services AIG GATX PPG Industries Air Products and Chemicals, Inc. GE Foundation PQ Corporation Allstate Foundation GlaxoSmithKline Procter & Gamble Altria Group, Inc. Glenmede Prudential Financial American Express Company Hillman Company PVR Partners, L.P. American International Group, Inc. Houghton Mifflin Quaker Chemical Corporation AmeriGas Propane, Inc. IBM Corporation Quest Diagnostics AON J.P. Morgan Chase Ross Arkema Inc. John Hancock Saint-Gobain Corporation Automatic Data Processing Johnson & Johnson Sandmeyer Steel Company AXA Foundation, Inc. JP Morgan Chase SAP Matching Gift Program Axiom Data, Inc. Kaplan Inc. Schering-Plough Foundation Bank of America Kellogg Schroder Investment Management Bemis Company Foundation KPMG LLP Shell Oil Company Berwind Corporation Liberty Mutual State Farm Companies Foundation BlackRock Lincoln Financial Group Subaru of America Boeing Company May Department Stores Sun Life Financial BP McDonald's Sun Microsystems, Inc Bristol-Myers Squibb Company McKesson Foundation Sunoco, Inc. C. R. Bard, Inc. Merck & Co., Inc. Tenet Healthcare Foundation CertainTeed Merrill Lynch Texas Instruments Charles Schwab Merrill Lynch ACE INA Foundation Chevron Corporation Microsoft AXA Foundation Chubb Group of Insurance Companies Minerals Technologies Inc. Dow Chemical Company CIGNA Foundation Mobil Foundation Inc.
    [Show full text]
  • 2015 Annual Report
    ANNUAL REPORT 2015 MARCH 2016 TO OUR SHAREHOLDERS ALEX GORSKY Chairman, Board of Directors and Chief Executive Officer This year at Johnson & Johnson, we are proud this aligned with our values. Our Board of WRITTEN OVER to celebrate 130 years of helping people Directors engages in a formal review of 70 YEARS AGO, everywhere live longer, healthier and happier our strategic plans, and provides regular OUR CREDO lives. As I reflect on our heritage and consider guidance to ensure our strategy will continue UNITES & our future, I am optimistic and confident in the creating better outcomes for the patients INSPIRES THE long-term potential for our business. and customers we serve, while also creating EMPLOYEES long-term value for our shareholders. OF JOHNSON We manage our business using a strategic & JOHNSON. framework that begins with Our Credo. Written OUR STRATEGIES ARE BASED ON over 70 years ago, it unites and inspires the OUR BROAD AND DEEP KNOWLEDGE employees of Johnson & Johnson. It reminds OF THE HEALTH CARE LANDSCAPE us that our first responsibility is to the patients, IN WHICH WE OPERATE. customers and health care professionals who For 130 years, our company has been use our products, and it compels us to deliver driving breakthrough innovation in health on our responsibilities to our employees, care – from revolutionizing wound care in communities and shareholders. the 1880s to developing cures, vaccines and treatments for some of today’s most Our strategic framework positions us well pressing diseases in the world. We are acutely to continue our leadership in the markets in aware of the need to evaluate our business which we compete through a set of strategic against the changing health care environment principles: we are broadly based in human and to challenge ourselves based on the health care, our focus is on managing for the results we deliver.
    [Show full text]
  • General Information - Automotive
    Group 0 General Information - Automotive GENERAL: This group contains information applicable to all other groups. Such items as lubrication, trouble- shooting of entire coach, storage, towing, and a description of the part number structure used by the Recreational Vehicle Division are included. SPECIFICS: As applicable ...Cleaning of Coach ...Grouping Key ...Jacking of Coach ...Lubrication of Coach ...Parts Structure Key ...Parts Tables (bolts, screws, nuts, tubing, wire, etc. ) ...Preventive Maintenance ...Servicing of Coach ...Specifications of Coach ...Storage of Coach ...Table of Contents ...Tools and Equipment ...Towing of Coach ...Troubleshooting of Coach FMC Corporation Motor Coach Division HFMC 333 Brokaw Road Box 664 Santa Clara California 95052 REPAIR PARTS LIST GROUP. MODEL All GROUP 0 GENERAL INFORMATION SCOPE All repair parts will be shipped F.O.B., FMC/ MCD Santa Clara, California Plant. This Repair Parts Catalog lists all serviceable parts required for motor homes floor plans "A", NOTE "J" and "M" built by FMC/MCD. It is divided into functional groups as indicated on the frontis- Always provide model and serial num- piece of this catalog. The functional group ber of coach and, if applicable, model system used by FMC/MCD is designed to enable and serial number of component for you to quickly find and order repair parts for which part(s) is ordered. your coach. For example, Group 9 "Brakes- Service, " contains a complete listing of all EMERGENCY PARTS ORDER serviceable brake parts used throughout the coach whether applied to the front or the rear When ordering repair parts on an "Emergency" brakes. basis, call FMC/MCD after you have filled out the Parts Order form number RVD-67 (refer to PART NUMBERS instructions given below).
    [Show full text]
  • FMC CORPORATION Annual Report 2003 FINANCIAL HIGHLIGHTS
    FMC CORPORATION Annual Report 2003 FINANCIAL HIGHLIGHTS (In millions, except per share amounts) 2003 REVENUE 2003 OPERATING PROFIT BY SEGMENT BY SEGMENT Industrial Industrial Chemicals Agricultural Chemicals $770.6 $34.0 $82.0 Products $640.1 Agricultural Products $102.1 $515.8 Specialty Specialty Chemicals Chemicals 2003 2002 Revenue $ 1,921.4 $ 1,852.9 Segment operating profit (1) $ 218.1 $ 230.9 Income from continuing operations $ 39.8 $ 69.1 Earnings per share from continuing operations: Basic $ 1.13 $ 2.06 Diluted $ 1.12 $ 2.01 Other data Restructuring and other charges (gains) per share (2) $ 0.78 $ 0.55 Earnings per share from continuing operations before restructuring and other charges (gains): (1) Basic $ 1.92 $ 2.61 Diluted $ 1.90 $ 2.55 Capital expenditures $ 87.0 $ 83.9 Research and development expenses 87.4 82.0 Net debt (total debt less cash and restricted cash) 856.3 902.8 (1) Earnings per share from continuing operations, before restructuring and other charges (gains), and segment operating profit (consolidated), are not measures of financial performance under generally accepted accounting principles and should not be considered in isolation from, or as substitutes for, income from continuing operations, net income, or earnings per share determined in accordance with generally accepted accounting principles, nor as the sole measures of our profitability. (2) Restructuring and other charges (gains) includes FMC’s share of charges recorded by Astaris, LLC, the phosphorus joint venture. There were no significant Astaris-related restructuring charges recorded in 2002. TO OUR SHAREHOLDERS Bill Walter, chairman of the board, president and chief executive officer While we continued to face difficult conditions in several of our businesses in 2003, we were able to meet or exceed our near-term goals and continued to make progress toward our longer term strategic objectives.
    [Show full text]
  • Corporations with Matching Gift Programs
    Corporations with Matching Gift Programs You can double your donation by asking your employer if they have a matching gift program. We’ve compiled this list of companies that match from outside sources, so we can’t guarantee its accuracy or completeness. Ask your employer if your donation is eligible! Abbot Laboratories Bechtel Group, Inc. Accenture Becton Dickinson ADVANTA Behring Diagnostics, Inc. Aetna, Inc. Beneficial Management Corporation Air Products & Chemicals, Inc. BOC Gases Allendale Mutual Insurance Company The Boeing Company Alliance Capital Bristol-Meyers Squibb Company Management Corporation, LP Brown & Williamson Tobacco Corporation AlliedSignal, Inc. Allmerica Financial Campbell Soup Company AMBAC, Inc. Cape Savings Bank Amerada Hess Corporation Cargill, Inc. American Cyanamid Company Carolina Power & Light Company American Express Company Carter-Wallace, Inc. American Home Products Corporation CBS, Inc. American Standard, Inc. Certain Teed Corporation Amgen, Inc. CGU Ammirati Puris Lintas Chase Manhattan Foundation The ARA Group, Inc. Chrysler Corporation Aramark Chubb & Son, Inc. ARCO Chemical Company Ciba Corning Diagnostics Corp. Arthur Anderson LLP Ciba-Geigy Corporation Aon Corporation Ciba Specialty Chemicals Applied Technology CIGNA Corporation Arthur Young CITGO Petroleum Corporation Atlantic City Electric Company Liz Claiborne Atlantic Electric CMS Energy AT&T CNA Insurance Company Automatic Data Processing, Inc. Coca Cola Aventis Behring L.L.C. Colgate-Palmolive Company Aventis Pharmaceuticals Products, Inc. Computer Associates International, Inc. Avery Dennison Corporation ConAgra, Inc. Avon Products, Inc. Conectiv Congoleum Corporation Ball Corporation Consumers Water Company Bankers Trust Company The Continental Corporation Bank of America Corning Incorporated Bank of Montreal Comair, Inc. The Bank of New York Crompton & Knowles Corporation Bankers Trust Company CSX, Inc.
    [Show full text]
  • UNITED STATES DISTRICT COURT DISTRICT of NEW JERSEY STEVEN HILL, Derivatively on Behalf of JOHNSON & JOHNSON, Plaintiff, V
    Case 3:20-cv-00774-FLW-TJB Document 1 Filed 01/23/20 Page 1 of 121 PageID: 1 UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY STEVEN HILL, Derivatively On Behalf Of Case No.:20-774 JOHNSON & JOHNSON, Plaintiff, SHAREHOLDER DERIVATIVE COMPLAINT v. ALEX GORSKY, ANNE M. MULCAHY, CHARLES PRINCE, WILLIAM D. PEREZ, IAN E. L. DAVIS, RONALD A. WILLIAMS, A. EUGENE WASHINGTON, MARK B. MCCLELLAN, D. SCOTT DAVIS, MARY C. BECKERLE, CAROL GOODRICH, MICHAEL E. SNEED, JOAN CASALVIERI, and TARA GLASGOW, Defendants, and, JOHNSON & JOHNSON, Nominal Defendant. Plaintiff Steven Hill (“Plaintiff”), by and through his undersigned counsel, derivatively on behalf of Nominal Defendant Johnson & Johnson (“J&J” or the “Company”), submits this Verified Shareholder Derivative Complaint (the “Complaint”). Plaintiff’s allegations are based upon his personal knowledge as to himself and his own acts, and upon information and belief, developed from the investigation and analysis by Plaintiff’s counsel, including a review of publicly available information, including filings by the Company with the U.S. Securities and Exchange Commission (“SEC”), press releases, news reports, analyst reports, investor conference transcripts, publicly available filings in lawsuits, and matters of public record. NATURE OF THE ACTION Case 3:20-cv-00774-FLW-TJB Document 1 Filed 01/23/20 Page 2 of 121 PageID: 2 1. This is a shareholder derivative action brought in the right, and for the benefit, of the Company against certain of its officers and directors seeking to remedy Defendants’ (as defined below) breach of fiduciary duties from February 22, 2013 to the present (”Relevant Period”). 2.
    [Show full text]
  • 7 Day Search
    7 Day Search http://interactive.wsj.com/dividends/retrieve.cgi?id=/text/wsjie/data... New Search: Search Results Help? December 22, 2004 Leader (U.S.) Mission Control For Citigroup, Scandal in Japan Shows Dangers of Global Sprawl Obsession With Bottom Line And Bickering Executives Created a 'Perfect Storm' A Scathing Internal Report By MITCHELL PACELLE, MARTIN FACKLER and ANDREW MORSE Staff Reporters of THE WALL STREET JOURNAL Nearly four years ago, warning lights began flashing at Citigroup Inc.'s Japanese private bank, tucked in a quiet office overlooking Tokyo's Imperial Palace. Koichiro Kitade, a marketing whiz who headed the office, was roping in hundreds of wealthy new clients. But he had a tin ear for regulation. In August 2001, Japan's Financial Services Agency flagged his group for infractions, including selling securities without prior authorization. Following a settlement, Citigroup dispatched Charles Whitehead, an American lawyer with Japanese experience, to serve as "country officer" in Japan. Regulators were told that Mr. Whitehead would share responsibility for compliance and control in all Citigroup's business units in Japan, from retail banking to corporate finance. Under the But Messrs. Whitehead and Kitade, who reported to different Microscope bosses in New York, clashed badly. And once again, the private bank spun out of control. By late last year, Japanese regulators A Big Loan to had found problems throughout the unit, and Citigroup's efforts Design School to mollify them spiraled into disarray. Internal bickering about Intensified who should talk to regulators, and what they should say, reached 1 of 7 12/23/2004 10:48 AM 7 Day Search http://interactive.wsj.com/dividends/retrieve.cgi?id=/text/wsjie/data..
    [Show full text]
  • Annual Report
    ANNUAL REPORT 2019 MARCH 2020 To Our Shareholders Alex Gorsky Chairman and Chief Executive Officer By just about every measure, Johnson & These are some of the many financial and Johnson’s 133rd year was extraordinary. strategic achievements that were made possible by the commitment of our more than • We delivered strong operational revenue and 132,000 Johnson & Johnson colleagues, who adjusted operational earnings growth* that passionately lead the way in improving the health exceeded the financial performance goals we and well-being of people around the world. set for the Company at the start of 2019. • We again made record investments in research and development (R&D)—more than $11 billion across our Pharmaceutical, Medical Devices Propelled by our people, products, and and Consumer businesses—as we maintained a purpose, we look forward to the future relentless pursuit of innovation to develop vital with great confidence and optimism scientific breakthroughs. as we remain committed to leading • We proudly launched new transformational across the spectrum of healthcare. medicines for untreated and treatment-resistant diseases, while gaining approvals for new uses of many of our medicines already in the market. Through proactive leadership across our enterprise, we navigated a constant surge • We deployed approximately $7 billion, of unique and complex challenges, spanning primarily in transactions that fortify our dynamic global issues, shifting political commitment to digital surgery for a more climates, industry and competitive headwinds, personalized and elevated standard of and an ongoing litigious environment. healthcare, and that enhance our position in consumer skin health. As we have experienced for 133 years, we • And our teams around the world continued can be sure that 2020 will present a new set of working to address pressing public health opportunities and challenges.
    [Show full text]
  • Caring for the World . . .One Person at a Time™ Inspires and Unites the People of Johnson & Johnson
    OUR CARING TRANSFORMS 2007 Annual Report Caring for the world . .one person at a time™ inspires and unites the people of Johnson & Johnson. We embrace research and science—bringing innovative ideas, products and services to advance the health and well-being of people. Employees of the Johnson & Johnson Family of Companies work with partners in health care to touch the lives of over a billion people every day, throughout the world. The people in our more than 250 companies come to work each day inspired by their personal knowledge that their caring transforms people’s lives . one person at a time. On the following pages, we invite you to see for yourself. Our Caring Transforms ON THE COVER Johnson & Johnson is founding sponsor and continues to support Safe Kids Worldwide®. For 20 years the organization has grown, now teaching prevention as a way to save children’s lives in 17 countries around the world. In Brazil, Nayra Yara da Paz de Jesus carefully washes her hands, a safe, healthy habit she and other children are learning from a local Safe Kids® program. Find out more in our story on page 22. C H A I R M A N ’ S L E T T E R To Our Shareholders Caring for the health and well-being of people throughout the world is an extraordinary business. It is a business where people are passionate about their work, because it matters. It matters to their families, to their communities and to the world. It is a business filled with tremendous opportunity for leadership and growth in the 21st century; a business where unmet needs still abound and where people around the world WILLIAM C.
    [Show full text]
  • Unpublished United States Court of Appeals for The
    Appeal: 10-1799 Doc: 23 Filed: 04/22/2011 Pg: 1 of 4 UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 10-1799 NEIL ALLRAN; TERRY SPOERLE; LESLIE J. DALE; ROY ARMSTRONG; RUTH BAKER; SALLY F. BARKER; JON BARRETT; SEVIM BASOGLU; MARY E. BECKHAM; O. EUGENE BELL; CHESANIE BEAM; RICHARD C. BIANCO; A. J. BIDDELL, Dr.; VERNON BIRT; BOBBY BLANTON; NORMAN BOSSEN; PATRICIA A. BOYCE; SYBLE E. BUNNEL; SHIRLEY A. BURK-DEWITT; MARTIN G. BURKLAND, Dr.; MARTIN G. BURKLAND, Mrs.; TINA CARRAWAY; TERRIE J. CARVER; RICHARD A. COAD, JR.; RICHARD K. COLBOURNE; PAT H. COONE; ISSA COOK; PAUL COOK; NANCY A. COOKE; NANCY A. COWELL; VIRGINIA M. DAVIS; VIRGINIA A. DAVIS; ALBOUT J. DE CICCO; LEONARD DEMARAY; KILEY DONNELL; WILLIAM DONNELL; LOIS FORTENER DOONAN; PAUL DRISCOLL; WILLIAM DRISCOLL; RUTH DUBOSE; PAUL L. ECKERT; VERONICA M. EGLI; CASEY ENGLAND; LEONARD ENGLAND; RHONDA ENGLAND; FAYE EUREY; SHIRL ELKINS; MARGARET A. GADLEY; WILLIAM GALBRAITH; JEAN GALBRAITH; WILLIAM R. GARREN; PAMELA GILCHRIST; PERLIE M. GILCHRIST; VIRGINIA M. GOETTER; RUSSELL B. GRAHAM; PERINEAU P. GRAMLING; LYNN GREENWALT; ABRAHAM GRINOCH; MICHAEL HALVERSON; MARTHA J. HARBSMEIER; NORECER B. HARLEY; MARY HARPER; NYBIUS N. HARRELL; ANGELA HARRISON; RAYE C. HATCHER; W. E. HAYNES; NANETTE R. HECKENDORN; SCOTT HENDERSON; DENNIS K. HICKMAN; MICHAEL T. HINES; MELBA L. HOBBS; TIMOTHY HUNT; MARNIE INMAN; ALFRED IZZO; WINDELL JACKSON; ROBERT L. KALLBREIER; RUTH KAMINO; SHARI KANTOR; RUTH J. KAVFMAN; TOM M. KING; LORETTA F. KING; MARGARET KITCHEN; RAY E. KNERR; STANLEY KORONA; SYLVIA LEASON; JOYCE C. LANGDON; VALERIE LAROUCHE; VIVIAN LASKO; ADRIANA LAV; ALEXIS LINGERFELT; WAYLON E. LYNN, JR.; REBECCA E.
    [Show full text]
  • Citi's Creator, Alone with His Regrets
    Citi’s Creator, Sandy Weill, Alone With His Regrets - NYTimes.com Page 1 of 5 This copy is for your personal, noncommercial use only. You can order presentation-ready copies for distribution to your colleagues, clients or customers here or use the "Reprints" tool that appears next to any article. Visit www.nytreprints.com for samples and additional information. Order a reprint of this article now. January 3, 2010 Citi’s Creator, Alone With His Regrets By KATRINA BROOKER “THIS is my final annual meeting as chairman,” says Sandy Weill, standing near the window of his office, peering at a grainy photograph of him and his wife on stage at Carnegie Hall more than three years ago. They are smiling broadly, and behind them is a packed house of cheering Citigroup shareholders. A huge banner dangling from the balcony reads “Thank You Sandy.” On that day, April 18, 2006, Citi’s share price was $48.48. After studying the photo for a few moments, Mr. Weill says quietly, “I thought the company was impregnable.” He knows now, of course, that he was wrong. Over the last two years, Mr. Weill has watched Citi — a company he built brick by brick during the final act of a 50-year career — nearly fall apart. Although every taxpayer in the country has paid for Citi’s outsize mistakes, for Mr. Weill the bank’s myriad woes are a commentary on his life’s work. “Sandy will forever be identified with Citigroup,” says Michael Armstrong, a Citi board member and a former chief of AT&T.
    [Show full text]
  • Abbott Laboratories Advanced Micro Devices, Inc
    FORTUNE 1000 CUSTOMERS equipped with the power to save lives 3M (3 Com Corporation) Gannett Co, Inc. Pittston Co 3M (3M Company) General Electric Pratt & Whitney Abbott Laboratories Gencorp Praxair Advanced Micro Devices, Inc. General Dynamics Corporation Procter & Gamble Agilent Technologies, Inc. General Mills Progressive Insurance AK Steel General Motors Purolator Alcoa Gillette Quantum Corporation Allstate Gold Kist, Inc. Raytheon Amazon Goldman Sachs Group, Inc. Readers Digest Amerada Hess Corporation Goodyear Reebok American Express Great Lakes Chemical Corp Revlon, Inc. Anadarko Petroleum Corporation Guidant Corporation Rockwell International AON Corporation Halliburton Company Rohm and Haas Company Apache Corporation Harley-Davidson Safeco Corporation Applied Materials Harris Corporation Sentry Insurance Ashland, Inc. Heinz Sherwin-Williams AT&T Hercules Incorporated Sierra Pacific Resources Ball Corporation Hewlett Packard Sisco Bank of America Corporation Hilton Spartan Stores Bank of New York Company, Inc. Hon Industries, Inc. Sprint Bear Stearns Companies, Inc. Honeywell Solectron Corporation Bethlehem Steel Hubbell Corporation Solutia, Inc. Blockbuster IBM Southern Company Boeing Intel Southern Union Company, Inc. Bristol-Myers Squibb International Paper Standard Register Company Cabot ITT Industries, Inc. State Farm Calpine Corporation Jabil Circuit, Inc. Steelcase, Inc. Carrier Corporation John Deere Textron, Inc. Caterpillar Johnson & Johnson The Gap Charter Communications, Inc. Johnson Controls Timberland Company Chevron
    [Show full text]